Polycystic Ovary Syndrome (PCOS) is a complicated endocrine condition marked by “irregularities in the reproductive system, metabolic problems, and hormone imbalances.” A complex interaction of genetic predisposition, hyperandrogenism, insulin resistance, and chronic inflammation is responsible for the genesis of PCOS. Menstrual abnormalities, hirsutism, and metabolic syndrome are among the clinical signs of the condition that are caused by pathophysiological processes such as altered hypothalamic-pituitary-ovarian (HPO) axis function. PCOS diagnosis necessitates a thorough assessment taking into account imaging, biochemical, and clinical data; differential diagnosis entails separating PCOS from other gynecological and endocrine conditions. PCOS treatment plans are customized to each patient’s unique symptoms and may involve supportive therapy, medication adjustments, and lifestyle changes. Healthcare professionals may maximize results and enhance the quality of life for PCOS-affected women by using a comprehensive approach to diagnosis and treatment.
McDonnell, R. and Hart, R.J. (2017) Pregnancy-Related Outcomes for Women with Polycystic Ovary Syndrome. Women’s Health, 13, 89-97. https://doi.org/10.1177/1745505717731971
Bulsara, J., Patel, P., Soni, A. and Acharya, S. (2021) A Review: Brief Insight into Polycystic Ovarian Syndrome. Endocrine and Metabolic Science, 3, Article ID: 100085. https://doi.org/10.1016/j.endmts.2021.100085
Jabeen, A., Yamini, V., Rahman Amberina, A., Dinesh Eshwar, M., Vadakedath, S., Begum, G.S., et al. (2022) Polycystic Ovarian Syndrome: Prevalence, Predisposing Factors, and Awareness among Adolescent and Young Girls of South India. Cureus, 14, e27943. https://doi.org/10.7759/cureus.27943
Barber, T.M., Hanson, P., Weickert, M.O. and Franks, S. (2019) Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clinical Medicine Insights: Re-productive Health, 13, 3. https://doi.org/10.1177/1179558119874042
Siddiqui, S., Mateen, S., Ahmad, R. and Moin, S. (2022) A Brief Insight into the Etiology, Genetics, and Immunology of Polycystic Ovarian Syndrome (PCOS). Journal of Assisted Reproduction and Genetics, 39, 2439-2473. https://doi.org/10.1007/s10815-022-02625-7
Khan, M.J., Ullah, A. and Basit, S. (2019) Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. The Application of Clinical Genetics, 12, 249-260. https://doi.org/10.2147/tacg.s200341
Ajmal, N., Khan, S.Z. and Shaikh, R. (2019) Polycystic Ovary Syndrome (PCOS) and Genetic Predisposition: A Review Article. European Journal of Obstetrics & Gynecology and Re-productive Biology: X, 3, Article ID: 100060. https://doi.org/10.1016/j.eurox.2019.100060
Harada, M. (2022) Path-ophysiology of Polycystic Ovary Syndrome Revisited: Current Understanding and Perspectives Regarding Future Research. Reproductive Medicine and Biology, 21, e12487. https://doi.org/10.1002/rmb2.12487
Barrett, E.S., Hoeger, K.M., Sathyanarayana, S., Abbott, D.H., Redmon, J.B., Nguyen, R.H.N., et al. (2018) Anogenital Distance in Newborn Daughters of Women with Polycystic Ovary Syndrome Indicates Fetal Testosterone Exposure. Journal of Developmental Origins of Health and Disease, 9, 307-314. https://doi.org/10.1017/s2040174417001118
Sánchez-Ferrer, M.L., Mendiola, J., Hernández-Peñalver, A.I., Corbalán-Biyang, S., Carmona-Barnosi, A., Prieto-Sánchez, M.T., et al. (2017) Pres-ence of Polycystic Ovary Syndrome Is Associated with Longer Anogenital Distance in Adult Mediterranean Women. Human Reproduction, 32, 2315-2323. https://doi.org/10.1093/humrep/dex274
Wu, Y., Zhong, G., Chen, S., Zheng, C., Liao, D. and Xie, M. (2017) Polycystic Ovary Syndrome Is Associated with Anogenital Distance, a Marker of Prenatal Androgen Exposure. Human Reproduction, 32, 937-943. https://doi.org/10.1093/humrep/dex042
Lin, S., Yang, Y., Chang, C.Y., Lin, C., Hsu, W., Ju, S., et al. (2019) Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis. International Journal of Environmental Research and Public Health, 16, Article No. 4816. https://doi.org/10.3390/ijerph16234816
Witchel, S.F., Oberfield, S.E. and Peña, A.S. (2019) Pol-ycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls. Journal of the Endocrine Society, 3, 1545-1573. https://doi.org/10.1210/js.2019-00078
Karkera, S., Agard, E. and Sankova, L. (2023) The Clinical Manifestations of Polycystic Ovary Syndrome (PCOS) and the Treatment Options. European Journal of Biology and Medical Science Research, 11, 57-91. https://doi.org/10.37745/ejbmsr.2013/vol11n15791
Gupta, A. and Deshpande, P. (2019) Causes and Prevalence of Factors Causing Infertility in a Public Health Facility. Journal of Human Re-productive Sciences, 12, 287-293. https://doi.org/10.4103/jhrs.jhrs_140_18
Teede, H.J., Misso, M.L., Costello, M.F., Dokras, A., Laven, J., Moran, L., et al. (2018) Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Human Reproduction, 33, 1602-1618. https://doi.org/10.1093/humrep/dey256
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., et al. (2006) Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. The Journal of Clinical Endocrinology & Metabolism, 91, 4237-4245. https://doi.org/10.1210/jc.2006-0178
Sidra, S., Tariq, M.H., Farrukh, M.J. and Mohsin, M. (2019) Evaluation of Clinical Manifestations, Health Risks, and Quality of Life among Women with Polycystic Ovary Syndrome. PLOS ONE, 14, e0223329. https://doi.org/10.1371/journal.pone.0223329
Dason, E.S., Koshkina, O., Chan, C. and Sobel, M. (2024) Diagnosis and Management of Polycystic Ovarian Syndrome. Canadian Medical Association Journal, 196, E85-E94. https://doi.org/10.1503/cmaj.231251
